Brookstone Capital Management raised its holdings in Clorox Co (NYSE:CLX) by 3.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,615 shares of the company’s stock after buying an additional 164 shares during the period. Brookstone Capital Management’s holdings in Clorox were worth $701,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Clorox by 0.8% in the 2nd quarter. Vanguard Group Inc. now owns 15,541,246 shares of the company’s stock valued at $2,379,520,000 after acquiring an additional 126,624 shares during the period. Parnassus Investments CA increased its position in Clorox by 2.9% during the 2nd quarter. Parnassus Investments CA now owns 4,634,090 shares of the company’s stock worth $709,526,000 after purchasing an additional 128,886 shares in the last quarter. Northern Trust Corp increased its position in Clorox by 0.6% during the 2nd quarter. Northern Trust Corp now owns 2,369,859 shares of the company’s stock worth $362,850,000 after purchasing an additional 14,792 shares in the last quarter. Morgan Stanley increased its position in Clorox by 8.1% during the 2nd quarter. Morgan Stanley now owns 2,192,928 shares of the company’s stock worth $335,759,000 after purchasing an additional 165,160 shares in the last quarter. Finally, Janus Henderson Group PLC increased its position in Clorox by 1.9% during the 2nd quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock worth $276,243,000 after purchasing an additional 33,032 shares in the last quarter. Hedge funds and other institutional investors own 78.45% of the company’s stock.
In other Clorox news, SVP Diego J. Barral sold 1,987 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Michael R. Costello sold 6,997 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the sale, the senior vice president now directly owns 29,016 shares in the company, valued at $4,716,840.96. The disclosure for this sale can be found here. Insiders have sold a total of 15,609 shares of company stock worth $2,497,443 over the last three months. Insiders own 1.14% of the company’s stock.
CLX opened at $149.70 on Monday. Clorox Co has a fifty-two week low of $143.58 and a fifty-two week high of $167.70. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55. The firm has a market capitalization of $18.74 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 5.04 and a beta of 0.40. The company’s 50 day moving average price is $154.09 and its two-hundred day moving average price is $154.98.
Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same period in the previous year, the firm posted $1.66 EPS. The company’s revenue for the quarter was down 3.8% compared to the same quarter last year. As a group, equities research analysts predict that Clorox Co will post 6.14 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be issued a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a yield of 2.83%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s payout ratio is 67.09%.
A number of equities analysts recently issued reports on CLX shares. UBS Group lowered their price objective on shares of Clorox from $128.00 to $125.00 and set a “sell” rating for the company in a research report on Thursday, October 3rd. Deutsche Bank lowered their price objective on shares of Clorox from $151.00 to $145.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Bank of America lowered their price objective on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a research report on Thursday, October 3rd. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $137.00 price objective (down from $143.00) on shares of Clorox in a research report on Thursday, October 3rd. Finally, Credit Suisse Group lowered their price objective on shares of Clorox from $172.00 to $168.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $152.25.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: How can you know how many shares are floating?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.